These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 1780532)

  • 1. [New pharmacologic perspectives in the therapy with antisecretory agents: omeprazole].
    Esplugues JV; García AG
    Rev Clin Esp; 1991 Apr; 188(6):301-5. PubMed ID: 1780532
    [No Abstract]   [Full Text] [Related]  

  • 2. Omeprazole: a new approach to gastric acid suppression.
    Buhl K; Clearfield HR
    Am Fam Physician; 1990 Apr; 41(4):1225-7. PubMed ID: 2321497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Omeprazole.
    Gazzard BG
    Br J Clin Pract; 1989 Nov; 43(11):408-11. PubMed ID: 2611096
    [No Abstract]   [Full Text] [Related]  

  • 4. [Omeprazole].
    Isal JP
    Gastroenterol Clin Biol; 1987 Nov; 11(11):768-80. PubMed ID: 3322924
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacological regulation of gastric acid secretion in the apical membrane of parietal cells; a new target for antisecretory drugs.
    Okabe S; Shimosako K; Amagase K
    J Physiol Pharmacol; 2001 Dec; 52(4 Pt 1):639-56. PubMed ID: 11787764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy, safety, and cost issues in managing patients with gastroesophageal reflux disease.
    Garnett WR
    Am J Hosp Pharm; 1993 Apr; 50(4 Suppl 1):S11-8. PubMed ID: 8097363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Omeprazole: blocks gastric acid secretion completely.
    Drug Ther Bull; 1990 Jun; 28(13):49-52. PubMed ID: 2131211
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition of acid secretion in guinea pigs by tricyclic antidepressants: comparison with ranitidine and omeprazole.
    Batzri S; Brugada O; Harmon JW; Rich NM
    J Pharmacol Exp Ther; 1988 Aug; 246(2):493-9. PubMed ID: 2841448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review article: immediate-release proton-pump inhibitor therapy--potential advantages.
    Howden CW
    Aliment Pharmacol Ther; 2005 Dec; 22 Suppl 3():25-30. PubMed ID: 16303034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Omeprazole: a comprehensive review.
    Massoomi F; Savage J; Destache CJ
    Pharmacotherapy; 1993; 13(1):46-59. PubMed ID: 8437967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A turnover model of irreversible inhibition of gastric acid secretion by omeprazole in the dog.
    Abelö A; Eriksson UG; Karlsson MO; Larsson H; Gabrielsson J
    J Pharmacol Exp Ther; 2000 Nov; 295(2):662-9. PubMed ID: 11046103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of ORF 17583, other histamine H2-receptor antagonists and omeprazole on gastric acid secretory states in rats and dogs.
    Katz LB; Tobia AJ; Shriver DA
    J Pharmacol Exp Ther; 1987 Aug; 242(2):437-42. PubMed ID: 2886642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of omeprazole on acid gastroesophageal reflux and gastric acidity in preterm infants with pathological acid reflux.
    Omari TI; Haslam RR; Lundborg P; Davidson GP
    J Pediatr Gastroenterol Nutr; 2007 Jan; 44(1):41-4. PubMed ID: 17204951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Omeprazole: mode of action and effect on acid secretion in animals.
    Wallmark B
    Methods Find Exp Clin Pharmacol; 1989; 11 Suppl 1():101-6. PubMed ID: 2657278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Advances in the knowledge of peptic-acid dependent diseases].
    Mazure PA; Pigliacampo J
    Acta Gastroenterol Latinoam; 1989; 19(3):165-73. PubMed ID: 2576850
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacokinetics and pharmacodynamics of acid-suppressive agents in patients with gastroesophageal reflux disease.
    Schentag JJ; Goss TF
    Am J Hosp Pharm; 1993 Apr; 50(4 Suppl 1):S7-10. PubMed ID: 8097364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of secretagogue selection on potency determinations for gastric acid antisecretory agents.
    Palumbo GJ; Nielsen ST
    Methods Find Exp Clin Pharmacol; 1988 Mar; 10(3):151-5. PubMed ID: 2898575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of low dose omeprazole on gastric secretion and plasma gastrin in patients with healed duodenal ulcer.
    Howden CW; Derodra JK; Burget DW; Hunt RH
    Hepatogastroenterology; 1986 Dec; 33(6):267-70. PubMed ID: 3804185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lansoprazole: a comprehensive review.
    Zimmermann AE; Katona BG
    Pharmacotherapy; 1997; 17(2):308-26. PubMed ID: 9085323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the new H2-receptor antagonist 3-amino-4-[4- [4- (1-piperidinomethyl)-2-pyridyloxy]-cis-2-butenylamino]-3-cyclobutene-1, 2- dione hydrochloride on gastric acid secretion and ulceration.
    Muramatsu M; Isobe Y; Arai I; Hirose-Kijima H; Usuki-Ito C; Nagai H; Aihara H; Otomo S
    Arzneimittelforschung; 1990 Jan; 40(1):49-54. PubMed ID: 1971169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.